Effects of semaglutide on subclinical cardiovascular health in people with HIV

More on GLP-1 and incretin signalling

• Semaglutide may protect kidneys by reducing vascular resistance

  Nature Medicine · 4 Oct 2026

  

• Risk factors for atherosclerosis diverge across vascular beds

  American Journal of Preventive Cardiology · 4 Oct 2026

  

• Orforglipron matches insulin glargine on cardiovascular safety

  Lancet · 4 Oct 2026

• Midlife CRP rises linked to body fat rather than menopause stage

  Research Square · 4 Oct 2026